American Oncology Network (AONCW) Stock Price, News & Analysis

Company Overview

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.04 to $0.26
• 52-Week Range: $0.00 to $0.67
• Volume: N/A
• Average Volume: 12,616 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AONCW Stock Analysis - Frequently Asked Questions

How have AONCW shares performed this year?

American Oncology Network's stock was trading at $0.23 on January 1st, 2024. Since then, AONCW stock has decreased by 77.8% and is now trading at $0.0510.
View the best growth stocks for 2024 here.

How do I buy shares of American Oncology Network?

Shares of AONCW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: NASDAQ:AONCW
• CUSIP: N/A
• CIK: 1839998
• Web: www.aoncology.com
• Phone: 833-886-1725
• Fax: N/A
• Employees: 1,525
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.34 billion
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A